QGEN - キアゲン (Qiagen N.V.)

QGENのニュース

   QIAGEN-Aktie legt zu: QIAGEN-Gründer empfiehlt Rücktritt des Aufsichtsratschefs  2020/08/17 10:38:00 Finanzen CH
"Ich bin froh, dass die Übernahme mit klarer Mehrheit gescheitert ist und QIAGEN unabhängig bleibt. Das ist gut für den Biotech -Standort Hilden, nun droht in der Hildener Zentrale keine Streichung mehr von Stellen in Zentralfunktionen", sagte…
   QIAGEN NV : Berenberg raises its recommendation to Buy | MarketScreener  2020/08/17 06:41:02 MarketScreener
Berenberg increases his rating from Neutral to Buy. The target price is being increased from EUR 39 to EUR 50. | August 17, 2020
   ANALYSE-FLASH: Berenberg hebt Qiagen auf 'Buy' - Ziel hoch auf 50 Euro  2020/08/17 00:00:00 Finanztreff
HAMBURG (dpa-AFX Broker) - Die Privatbank Berenberg hat Qiagen von 'Hold' auf 'Buy' hochgestuft und das Kursziel von 39 auf 50 Euro angehoben. Das …
   Nach geplatzter Übernahme: „Ich bin froh, dass Qiagen unabhängig bleibt“  2020/08/15 03:00:00 Rheinische Post
Mitgründer Detlev Riesner sieht den Biotech-Standort Hilden gestärkt. Nach dem geplatzten Thermo-Fisher-Deal empfiehlt er Chefkontrolleur Hakan Björklund den Rücktritt: „Der Aufsichtsrat hat nicht gut nachverhandelt.“
   GlobalData : Thermo Fisher's failed Qiagen acquisition will not significantly affect its future growth | MarketScreener  2020/08/14 21:18:02 MarketScreener
14 Aug 2020 Thermo Fisher's failed Qiagen acquisition will not significantly affect its future growth Posted in Medical Devices Following… | August 14, 2020
   The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive  2020/05/21 12:01:32 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.) ADC Therapeutics SA (NYSE: ADCT ) (went public May 15) Allogene Therapeutics Inc (NASDAQ: ALLO ) Ascendis Pharma A/S (NASDAQ: ASND ) (announced first-quarter results) Altimmune Inc (NASDAQ: ALT ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Cue Biopharma Inc (NASDAQ: CUE ) (reacted to first-quarter results) Evoke Pharma Inc (NASDAQ: EVOK ) (announced FDA's conditional approval for the brand name Gimoti for its nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis) GENMAB A/S/S ADR (NASDAQ: GMAB ) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Novo Nordisk A/S (NYSE: NVO ) PDL BioPharma Inc (NASDAQ: PDLI ) Pulmatrix Inc (NASDAQ: PULM ) Qiagen NV (NYSE: QGEN ) Soleno Therapeutics Inc (NASDAQ: SLNO ) Surface Oncology Inc (NASDAQ: SURF ) - announced an oncology partnership with Merck & Co., Inc. (NYSE: MRK ) VBI Vaccines Inc (NASDAQ: VBIV ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) (announced $20-million Series A financing to establish a Chinese joint venture) Down In The Dumps (Biotech stocks that hit 52-week lows on May 20.) Genfit SA (NASDAQ: GNFT ) RA Medical Systems Inc (NYSE: RMED ) (priced its 22.22-million-share common stock offering at 45 cents per share) Stocks In Focus Gilead-Galapagos Drug Produces Mixed Results In Ulcerative Colitis Study Gilead Sciences, Inc. (NASDAQ: GILD ) and GALAPAGOS NV/S ADR (NASDAQ: GLPG ) announced top-line results from the Phase 2b/3 trial evaluating the efficacy and safety of filgotinib in adult patients with moderately to severely active ulcerative colitis showing mixed results.
   Biotech: Thermo Fisher startet Übernahmeangebot für Qiagen  2020/05/18 08:28:06 Handelsblatt
Der US-Laborausrüster will mehr als zehn Milliarden Euro für die deutsche Biotechfirma zahlen. Die Annahmefrist für Aktionäre läuft nun bis zum 27. Juli.
   Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.  2020/05/18 07:15:00 PR Newswire
WALTHAM, Mass., May 18, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published the offer document (the "Offer Document") for its voluntary tender offer (the "Tender Offer") for all of the ordinary shares of QIAGEN N.V. (NYSE:…
   Can Qiagen (QGEN) Run Higher on Rising Earnings Estimates?  2020/05/12 16:20:05 Zacks Investment Research
Qiagen (QGEN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
   Adani Transmission Q4 profit falls 60 pc to Rs 59 crore on one-time write off  2020/05/09 10:15:27 Sify.com
Ahmedabad (Gujarat): Adani Transmission Ltd (ATL) on Saturday reported 60 per cent plunge in its Q4 (January to March) profit after tax at Rs 59 crore compared to Rs 147 crore in the corresponding period of previous fiscal. The decline was primarily due to one-time write off finance sunk cost of Rs 185 crore (non-cash item), the company said in a statement. Q4 FY20 revenue came lower by 3 per cent year-on-year at Rs 2,220 crore due to lower share of distribution business on account of subdued power demand by industries. The operational earnings before interest, taxes, depreciation and amortisation (EBITDA) of Rs 893 crore were up by 2 per cent. Transmission operational EBITDA of Rs 618 crore was up by 18 per cent. "ATL continues to focus on freeing up its equity, reducing cost of debt and bringing in marquee partners to set global corporate practices," it said. The company completed its maiden US private placement of 400 million dollars in February to March. It also completed the process of investment by Qatar Investment Authority (QIA) investment in subsidiary company Adani Electricity Mumbai Ltd (AEML).
   Can Qiagen (QGEN) Run Higher on Rising Earnings Estimates?  2020/05/12 16:20:05 Zacks Investment Research
Qiagen (QGEN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
   Adani Transmission Q4 profit falls 60 pc to Rs 59 crore on one-time write off  2020/05/09 10:15:27 Sify.com
Ahmedabad (Gujarat): Adani Transmission Ltd (ATL) on Saturday reported 60 per cent plunge in its Q4 (January to March) profit after tax at Rs 59 crore compared to Rs 147 crore in the corresponding period of previous fiscal. The decline was primarily due to one-time write off finance sunk cost of Rs 185 crore (non-cash item), the company said in a statement. Q4 FY20 revenue came lower by 3 per cent year-on-year at Rs 2,220 crore due to lower share of distribution business on account of subdued power demand by industries. The operational earnings before interest, taxes, depreciation and amortisation (EBITDA) of Rs 893 crore were up by 2 per cent. Transmission operational EBITDA of Rs 618 crore was up by 18 per cent. "ATL continues to focus on freeing up its equity, reducing cost of debt and bringing in marquee partners to set global corporate practices," it said. The company completed its maiden US private placement of 400 million dollars in February to March. It also completed the process of investment by Qatar Investment Authority (QIA) investment in subsidiary company Adani Electricity Mumbai Ltd (AEML).
   Dax aktuell: Dax steigt weiter – Laborausrüster Qiagen auf 19-Jahres-Hoch  2020/05/08 07:26:55 Handelsblatt
Der deutsche Aktienmarkt bleibt im Aufwind. Börsianer hoffen auf eine doppelte Entspannung: in der Corona-Pandemie und im Zollstreit USA-China. Qiagen-Aktien klettern auf ein Rekordhoch.
   QIAGEN (QGEN) Q1 Earnings Lag Estimates, Operating Margin Up  2020/05/07 14:40:00 Zacks Investment Research
QIAGEN (QGEN) registered robust revenue growth across all geographies and each of its operating segments in Q1 despite the coronavirus-led economic crisis.
   DAX startet etwas fester -- Asiens Börsen uneinheitlich -- HeidelbergCement spürt Corona-Folgen -- Munich Re mit Gewinneinbruch -- Conti kappt Investitionen -- PUMA, Evonik, QIAGEN, Lyft im Fokus  2020/05/07 05:00:27 FinanzenNet
Hoher Verlust bei Koenig & Bauer - Hoffnungsschimmer Auftragseingang. Mindestannahmeschwelle bis Sixt Leasing deutlich überschritten. Air France-KLM erwartet nach Milliardenverlust noch heftigere Corona-Folgen. Zalando erwartet 2020 zweistelliges Wachstum und schwarze Zahlen im Gesamtjahr. ElringKlinger erwartet schwierige Zeiten. CompuGroup profitiert von Nachfrage nach Videosprechstunde. 07.05.2020

calendar